Clinical Trials Browser

Phase 2 × Genomic Instability × Vemurafenib × Clear all

NCT02314481 2025-05-23

DARWINII

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Genomic Instability